Assessment of the Efficacy of Procalcitonin, C-Reactive Protein and Albumin Levels-Guided Antibiotics Use in Sepsis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis reduced antibiotic duration by 1.5 days in sepsis patients, suggesting cost benefits of using biomarkers.

The biomarker-guided approach reduced the duration of antibiotic therapy significantly, improving treatment efficiency.
Patients in the biomarker group experienced lower hospital costs, totaling 20,000 CNY compared to 24,000 CNY in standard care.
Assessment of 127 adult sepsis patients was conducted to compare standard care with biomarker-guided therapy.
These findings may highlight the systemic advantages of incorporating biomarkers into sepsis treatment protocols.

Cao et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark